large cell lymphoma, unclassifiable
GPTKB entity
Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Oncology
|
gptkbp:can_detect |
blood tests
|
gptkbp:can_lead_to |
secondary cancers
|
gptkbp:caused_by |
genetic mutations
chemical exposure viral infections |
gptkbp:diagnosis |
CT scan
variable biopsy flow cytometry imaging tests immunohistochemistry PET scan |
https://www.w3.org/2000/01/rdf-schema#label |
large cell lymphoma, unclassifiable
|
gptkbp:is_a |
gptkb:non-Hodgkin_lymphoma
|
gptkbp:is_associated_with |
environmental factors
immunosuppression age over 60 poor immune response |
gptkbp:is_characterized_by |
rapid growth
poor prognosis cytogenetic abnormalities high proliferation index immunophenotypic features high risk of relapse extramedullary involvement large atypical cells multifocal involvement |
gptkbp:is_common_in |
gptkb:children
adults females males |
gptkbp:is_part_of |
hematology
cancer research hematologic malignancies lymphoproliferative disorders lymphoma category |
gptkbp:is_related_to |
gptkb:Oncology
gptkb:HIV/_AIDS autoimmune diseases genetic predisposition chronic inflammation |
gptkbp:is_studied_in |
gptkb:guidelines
clinical trials oncology research pathology studies |
gptkbp:occurs_in |
bone marrow
lymph nodes spleen |
gptkbp:scientific_classification |
gptkb:aggressive_lymphoma
|
gptkbp:symptoms |
weight loss
fever night sweats swollen lymph nodes |
gptkbp:treatment |
gptkb:immunotherapy
palliative care clinical trials radiation therapy chemotherapy targeted therapy stem cell transplant novel therapies radiolabeled antibodies |
gptkbp:bfsParent |
gptkb:Oncology
|
gptkbp:bfsLayer |
4
|